Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons

Trends in Neurosciences

Volumn 29, Issue 5, 2006, Pages 257-262

  Anderson, Christopher M ^a   Nedergaard, Maiken ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRILLIANT BLUE; PURINE P2X7 RECEPTOR; SURAMIN;

CELL FUNCTION; CONSENSUS; IMMUNOREACTIVITY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; STAINING; SYNAPSE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; BRAIN; CELL SURVIVAL; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEURONS; RECEPTORS, PURINERGIC P2; SYNAPTIC TRANSMISSION; TISSUE DISTRIBUTION;

EID: 33646124242     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2006.03.003     Document Type: Review

References (50)

1. Surprenant A., et al. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272 (1996) 735-738
2. Collo G., et al. Tissue distribution of the P2X7 receptor. Neuropharmacology 36 (1997) 1277-1283
3. Brandle U., et al. Expression of the P2X7-receptor subunit in neurons of the rat retina. Mol. Brain Res. 62 (1998) 106-109
4. Deuchars S.A., et al. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J. Neurosci. 21 (2001) 7143-7152
5. Ishii K., et al. Neuron-specific distribution of P2X7 purinergic receptors in the monkey retina. J. Comp. Neurol. 459 (2003) 267-277
6. Puthussery T., and Fletcher E.L. Synaptic localization of P2X7 receptors in the rat retina. J. Comp. Neurol. 472 (2004) 13-23
7. Moores T.S., et al. Properties of presynaptic P2X7-like receptors at the neuromuscular junction. Brain Res. 1034 (2005) 40-50
8. Armstrong J.N., et al. Activation of presynaptic P2X7-like receptors depresses mossy fiber-CA3 synaptic transmission through p38 mitogen-activated protein kinase. J. Neurosci. 22 (2002) 5938-5945
9. Sperlagh B., et al. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J. Neurochem. 81 (2002) 1196-1211
10. Deng Z., and Fyffe R.E. Expression of P2X7 receptor immunoreactivity in distinct subsets of synaptic terminals in the ventral horn of rat lumbar spinal cord. Brain Res. 1020 (2004) 53-61
11. Wang X., et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat. Med. 10 (2004) 821-827
12. Sim J.A., et al. Reanalysis of P2X7 receptor expression in rodent brain. J. Neurosci. 24 (2004) 6307-6314
13. Kukley M., et al. Ecto-nucleotidases and nucleoside transporters mediate activation of adenosine receptors on hippocampal mossy fibers by P2X7 receptor agonist 2′-3′-O-(4-benzoylbenzoyl)-ATP. J. Neurosci. 24 (2004) 7128-7139
14. 7 receptors. J. Biol. Chem. 276 (2001) 125-132
15. Sikora A., et al. Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism. J. Immunol. 163 (1999) 558-561
16. Le Feuvre R., et al. Extracellular ATP and P2X7 receptors in neurodegeneration. Eur. J. Pharmacol. 447 (2002) 261-269
17. Labasi J.M., et al. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168 (2002) 6436-6445
18. Chessell I.P., et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114 (2005) 386-396
19. 7 knockout mice. FEBS Lett. 579 (2005) 3783-3788
20. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 82 (2002) 1013-1067
21. Gonzalez F.A., et al. Permeabilization of transformed mouse fibroblasts by 3′-O-(4-benzoyl)benzoyl adenosine 5′-triphosphate and the desensitization of the process. J. Cell. Physiol. 139 (1989) 109-115
22. el-Moatassim C., and Dubyak G.R. A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1.2F5 macrophages. J. Biol. Chem. 267 (1992) 23664-23673
23. Bianchi B.R., et al. Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur. J. Pharmacol. 376 (1999) 127-138
24. Evans R.J., et al. Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol. Pharmacol. 48 (1995) 178-183
25. Di Virgilio F. Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only target. Br. J. Pharmacol. 140 (2003) 441-443
26. Murgia M., et al. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem. 268 (1993) 8199-8203
27. 7 receptors. Mol. Pharmacol. 58 (2000) 82-88
28. Chessell I.P., et al. Effects of antagonists at the human recombinant P2X7 receptor. Br. J. Pharmacol. 124 (1998) 1314-1320
29. Virginio C., et al. Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology 36 (1997) 1285-1294
30. Humphreys B.D., et al. Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol. Pharmacol. 54 (1998) 22-32
31. 2+ and kills retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 46 (2005) 2183-2191
32. Innocenti B., et al. ATP-induced non-neuronal cell permeabilization in the rat inner retina. J. Neurosci. 24 (2004) 8577-8583
33. Ireland M.F., et al. P2X7-like receptor subunits enhance excitatory synaptic transmission at central synapses by presynaptic mechanisms. Neuroscience 128 (2004) 269-280
34. Gordon G.R., et al. Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. Nat. Neurosci. 8 (2005) 1078-1086
35. Cavaliere F., et al. Synaptic P2X7 and oxygen/glucose deprivation in organotypic hippocampal cultures. J. Cereb. Blood Flow Metab. 24 (2004) 392-398
36. Le Feuvre R.A., et al. Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J. Cereb. Blood Flow Metab. 23 (2003) 381-384
37. Nieber K., et al. Brain hypoxia: effects of ATP and adenosine. Prog. Brain Res. 120 (1999) 287-297
38. Ray S.K., et al. Molecular mechanisms in the pathogenesis of traumatic brain injury. Histol. Histopathol. 17 (2002) 1137-1152
39. Chessell I.P., et al. Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells. Br. J. Pharmacol. 121 (1997) 1429-1437
40. Kaiho H., et al. Identification of P2X7 (P2Z) receptor in N18TG-2 cells and NG108-15 cells. J. Neurochem. 70 (1998) 951-957
41. Lazarowski E.R., et al. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol. Pharmacol. 64 (2003) 785-795
42. Newman E.A. Propagation of intercellular calcium waves in retinal astrocytes and Muller cells. J. Neurosci. 21 (2001) 2215-2223
43. Gourine A.V., et al. ATP is a mediator of chemosensory transduction in the central nervous system. Nature 436 (2005) 108-111
44. Pellegatti P., et al. A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol. Biol. Cell 16 (2005) 3659-3665
45. Joseph S.M., et al. Colocalization of ATP release sites and ecto-ATPase activity at the extracellular surface of human astrocytes. J. Biol. Chem. 278 (2003) 23331-23342
46. Chakfe Y., et al. ADP and AMP induce interleukin-1β release from microglial cells through activation of ATP-primed P2X7 receptor channels. J. Neurosci. 22 (2002) 3061-3069
47. Seman M., et al. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19 (2003) 571-582
48. Okazaki I.J., and Moss J. Characterization of glycosylphosphatidylinositiol-anchored, secreted, and intracellular vertebrate mono-ADP-ribosyltransferases. Annu. Rev. Nutr. 19 (1999) 485-509
49. Elssner A., et al. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release. J. Immunol. 172 (2004) 4987-4994
50. Sluyter R., et al. Extracellular ATP increases cation fluxes in human erythrocytes by activation of the P2X7 receptor. J. Biol. Chem. 279 (2004) 44749-44755